logo
Plus   Neg
Share
Email

Teva Pharmaceutical Industries Limited Q2 adjusted earnings Beat Estimates

Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):

-Earnings: -$241 million in Q2 vs. -$6035 million in the same period last year.
-EPS: -$0.24 in Q2 vs. -$5.94 in the same period last year.
-Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $794 million or $0.78 per share for the period.
-Analysts projected $0.64 per share
-Revenue: $4.70 billion in Q2 vs. $5.72 billion in the same period last year.

-Guidance:
Full year EPS guidance: $2.55 - $2.80
Full year revenue guidance: $18.5 - $19.0 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT